Evidence map›Paper›PMID 39747459›Full record

ArticleScientific reports2025

Galactin-8 DNA methylation mediates macrophage autophagy through the MAPK/mTOR pathway to alleviate atherosclerosis.

Bing Xia, Yan-Lin Lu, Jin Peng, Jing-Wei Liang, Fang-Qin Li, Jiu-Yang Ding, Chang-Wu Wan, Cui-Yun Le, Jia-Lin Dai, Jie-Wang and 2 more

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. mTOR Signaling in Macrophages: All Depends on the Context.International journal of molecular sciences · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Bing XiaSchool of Forensic Medicine, Guizhou Medical University, Guiyang, 550004, China.
Yan-Lin LuSchool of Forensic Medicine, Guizhou Medical University, Guiyang, 550004, China.
Jin PengSchool of Forensic Medicine, Guizhou Medical University, Guiyang, 550004, China.
Jing-Wei LiangSchool of Forensic Medicine, Guizhou Medical University, Guiyang, 550004, China.
Fang-Qin LiSchool of Forensic Medicine, Guizhou Medical University, Guiyang, 550004, China.
Jiu-Yang DingSchool of Forensic Medicine, Guizhou Medical University, Guiyang, 550004, China.
Chang-Wu WanSchool of Forensic Medicine, Guizhou Medical University, Guiyang, 550004, China.
Cui-Yun LeSchool of Forensic Medicine, Guizhou Medical University, Guiyang, 550004, China.
Jia-Lin DaiSchool of Forensic Medicine, Guizhou Medical University, Guiyang, 550004, China.
Jie-WangSchool of Forensic Medicine, Guizhou Medical University, Guiyang, 550004, China.
Bing GuoSchool of Basic Medicine, Guizhou Medical University, Guiyang, 550004, China. guobingbs@126.com.
Jiang HuangSchool of Forensic Medicine, Guizhou Medical University, Guiyang, 550004, China. mmm_hj@126.com.

Funding

Gui zhou Provincial Science and Technology Program Qiankehe Foundation- ZK[2022] General 357The National Natural Science Foundation of China 82060340
6 · The paper itself

Abstract

DNA methylation modifications are an important mechanism affecting the process of atherosclerosis (AS). Previous studies have shown that Galectin-8 (GAL8) DNA methylation level is associated with sudden death of coronary heart disease or acute events of coronary heart disease. However, the mechanism of GAL8 DNA methylation and gene expression in AS has not been elucidated, prompting us to carry out further research on it. ApoE

Indexed as

AtherosclerosisAutophagyDNA MethylationMacrophagesTOR Serine-Threonine KinasesAnimalsDisease Models, AnimalFoam CellsHumansMaleMAP Kinase Signaling SystemMiceMice, Inbred C57BLSignal TransductionmTOR protein, mouseTOR Serine-Threonine KinasesAtherosclerosisCoronary heart diseaseGAL-8 promoter methylationMAPK/mTOR signaling Pathway

Identifiers

PMID39747459
PMCPMC11695939

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.